Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gastrointestinal 1CNS 1

Conditions

Oligodendroglioma 2Neuroblastoma 2Glioblastoma 2Astrocytoma 2Sezary Syndrome 1Rhabdomyosarcoma 1Recurrence 1Osteosarcoma 1Optic Nerve Glioma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplasms, Neuroepithelial 1Mycosis Fungoides 1Lymphoproliferative Disorders 1Lymphoma, T-Cell, Peripheral 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma 1Leukemia, Myelomonocytic, Juvenile 1Intraocular Lymphoma 1Immunoblastic Lymphadenopathy 1Hodgkin Disease 1Hepatoblastoma 1Gliosarcoma 1Ependymoma 1Dendritic Cell Sarcoma, Interdigitating 1Central Nervous System Neoplasms 1Burkitt Lymphoma 1Brain Stem Neoplasms 1

Interventions

Ifosfamide 5Doxorubicin 4Specimen Handling 3Methotrexate 3Etoposide 3Cisplatin 3Sorafenib 2Granulocyte Colony-Stimulating Factor 2Filgrastim 2sodium thiosulfate 1sargramostim 1pepinemab 1peginterferon alfa-2b 1mifamurtide 1merphos 1lorukafusp alfa 1irinotecan sucrosofate 1imetelstat 1etoposide phosphate 1Zoledronic Acid 1X-Rays 1Thrombopoietin 1Thoracotomy 1Thoracostomy 1Thoracoscopy 1Surgical Procedures, Operative 1Reverse Transcriptase Polymerase Chain Reaction 1Restraint, Physical 1Razoxane 1Radiotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Osteosarcoma × imetelstat × Clear all
NCT02011126 2018-08-07

Imetelstat Sodium in Treating Younger Patients With Relapsed or Refractory Solid Tumors

Children's Oncology Group

Phase 2 Withdrawn
CNSGastrointestinalSarcoma

Neuroblastoma, Rhabdomyosarcoma, Osteosarcoma, Hepatoblastoma, Neuroectodermal Tumors, Primitive, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡